Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wisinski

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Physical Review Letters|May 6, 1985
Direct measurement of charmed D+ and D0 semileptonic branching ratiosBaltrusaitis, Becker, Blaylock, et al.
Physical Review Letters|February 25, 1991
Measurement of the hadronic structure of semileptonic D0 and D+ decaysBai, Bolton, Brown, et al.
Clinical Breast Cancer|January 17, 2025
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Sergey Tarima, et al.
Science Translational Medicine|September 13, 2021
Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxelChristina M Scribano, Jun Wan, Karla Esbona, et al.
Physical Review Letters|October 28, 1985
tau leptonic branching ratios and a search for Goldstone-boson decayBaltrusaitis, Becker, Blaylock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN TrialKevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Physical Review Letters|September 10, 1990
Observation of a pseudoscalar state in J/ psi --> gamma phi phi near phi phi thresholdBai, Blaylock, Bolton, et al.
JCO Precision Oncology|August 8, 2022
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-BPhilippe L Bedard, Shuli Li, Kari B Wisinski, et al.
Physical Review Letters|July 13, 1987
Study of the KK-bar pi final state in J/ psi hadronic decaysBecker, Blaylock, Bolton, et al.
Physical Review Letters|November 12, 1990
Partial-wave analysis of J/ psi --> gamma K0SK+/- pi +/-Bai, Blaylock, Bolton, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Physical Review Letters|May 6, 1985
Direct measurement of charmed D+ and D0 semileptonic branching ratiosBaltrusaitis, Becker, Blaylock, et al.
Physical Review Letters|February 25, 1991
Measurement of the hadronic structure of semileptonic D0 and D+ decaysBai, Bolton, Brown, et al.
Clinical Breast Cancer|January 17, 2025
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Sergey Tarima, et al.
Science Translational Medicine|September 13, 2021
Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxelChristina M Scribano, Jun Wan, Karla Esbona, et al.
Physical Review Letters|October 28, 1985
tau leptonic branching ratios and a search for Goldstone-boson decayBaltrusaitis, Becker, Blaylock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN TrialKevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Physical Review Letters|September 10, 1990
Observation of a pseudoscalar state in J/ psi --> gamma phi phi near phi phi thresholdBai, Blaylock, Bolton, et al.
JCO Precision Oncology|August 8, 2022
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-BPhilippe L Bedard, Shuli Li, Kari B Wisinski, et al.
Physical Review Letters|July 13, 1987
Study of the KK-bar pi final state in J/ psi hadronic decaysBecker, Blaylock, Bolton, et al.
Physical Review Letters|November 12, 1990
Partial-wave analysis of J/ psi --> gamma K0SK+/- pi +/-Bai, Blaylock, Bolton, et al.
Pageof 14